Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP379328.RA6ONViVUXAeSca_uaoI3KyS9RrmBvudCSo62aX7aaRFg130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379328.RA6ONViVUXAeSca_uaoI3KyS9RrmBvudCSo62aX7aaRFg130_provenance.
• NP268618.RAMK21Y2W3R3YetSob5aU0kAvTRgqQbYVhlXaKuX5hh2k130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268618.RAMK21Y2W3R3YetSob5aU0kAvTRgqQbYVhlXaKuX5hh2k130_provenance.
• NP321602.RAkp7x_3p9qrr55MswueJ2pq5dgSoEE482KtzDref0ZVo130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321602.RAkp7x_3p9qrr55MswueJ2pq5dgSoEE482KtzDref0ZVo130_provenance.
• NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378039.RAKMlE2YFVVOz8JQsSZ9QHyP_BdDOsBHJY8HdIpXmANeU130_provenance.
• NP472428.RAfEdaQi8PYYKeMBQySvUCdN4upKHb_3PEZegWXNLeEYk130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472428.RAfEdaQi8PYYKeMBQySvUCdN4upKHb_3PEZegWXNLeEYk130_provenance.
• NP488141.RAWUXcpjIhVkwBS-LrQmTymT2j_6B0Acpv3FbooPSs4Z4130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488141.RAWUXcpjIhVkwBS-LrQmTymT2j_6B0Acpv3FbooPSs4Z4130_provenance.
• NP342925.RAP-C0RrMagnZYv15-yBVyfISVmFD1i6A_YYSZkrejkB4130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342925.RAP-C0RrMagnZYv15-yBVyfISVmFD1i6A_YYSZkrejkB4130_provenance.
• NP252541.RAfGjoQSxr2AjiwV5ICVIFX9aaYHnkhBs2ZJkTzIpdd6o130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252541.RAfGjoQSxr2AjiwV5ICVIFX9aaYHnkhBs2ZJkTzIpdd6o130_provenance.
• NP338498.RATyjr3qKQImwOM4NQFZVIlVuHC6IZCnaQngJhBHIv9I0130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338498.RATyjr3qKQImwOM4NQFZVIlVuHC6IZCnaQngJhBHIv9I0130_provenance.
• NP282688.RAbPvUfx5rGejMuKPQvTU8BKkLu6Uho2Vg0_mBhClGdbY130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282688.RAbPvUfx5rGejMuKPQvTU8BKkLu6Uho2Vg0_mBhClGdbY130_provenance.
• NP833669.RARrEkwZ9hg3qGdU66uFaVIFsR2i4dXRr61IzqOthPIOU130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833669.RARrEkwZ9hg3qGdU66uFaVIFsR2i4dXRr61IzqOthPIOU130_provenance.
• NP838361.RAWHUuqrxiDWdYp8uMQXM_xddXEeZVobo9UKs-sYpdzvY130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838361.RAWHUuqrxiDWdYp8uMQXM_xddXEeZVobo9UKs-sYpdzvY130_provenance.
• NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005004.RABK1gNNVb-wup3Qb9rmMK0URITMcQ23wLw4rr9rPVdPc130_provenance.
• NP642174.RAyjf6iIycg1PMLTeCQRls7oa2v5YPDKZdMySpOY-JvvI130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642174.RAyjf6iIycg1PMLTeCQRls7oa2v5YPDKZdMySpOY-JvvI130_provenance.
• NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.